Hemodialysis patients may be particularly vulnerable to adverse events related to these agents, which are cleared by the kidney, reports MedicalResearch.com.

Gabapentin and pregabalin use were associated with risk for altered mental status, fall, and fracture, and in some cases, even at doses that would be considered safe for use in this population.